Condensed Interim Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from Operating Activities
Net Loss	$ (1,649,872)	$ (1,032,951)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	287,999	210,741
Bad debt expense (recovery)	48,151	(73,895)
Change in fair market value of warrant liability	(43,828)	311,400
Loss on change in fair market value of contingent consideration (Note 2)	240,000
Gain on settlement of contingent consideration (Note 2)	(1,700,000)
Loss on impairment of goodwill (Note 2)	1,138,203
Amortization of right-of-use asset	97,618
Depreciation and amortization	467,746	100,109
Amortization of debt discount	4,036
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	19,140	(335,766)
Costs and estimated earnings in excess of billings	(8,898)
Inventory	(1,624,368)	45,880
Vendor deposits	619,070	8,767
Prepaid expense and other current assets	(182,273)	(486,997)
Accounts payable and accrued expenses	468,667	(141,729)
Billings in excess of costs and earnings on uncompleted contracts	(121,665)
Deferred revenue	175,780	(178,732)
Operating lease payments	(94,299)
Total Adjustments	(208,921)	(540,222)
Net Cash Used in Operating Activities	(1,858,793)	(1,573,173)
Cash Flows From Investing Activities
Cash paid for patent costs	(672)	(14,435)
Purchase of machinery and equipment	(16,111)
Acquisitions, net of cash acquired (Note 2)	(10)	(760,293)
Note receivable, related party (Note 10)		(500,000)
Net Cash Used in Investing Activities	(16,793)	(1,274,728)
Cash Flows From Financing Activities
Payments on financing leases	(1,738)	(1,594)
Proceeds from warrant exercise		1,157
Dividends to preferred shareholders	(362,250)
Proceeds from equity raises, net	1,092,000
Net Cash Provided by (Used in) Financing Activities	728,012	(437)
Net Decrease in Cash, restricted cash, and equivalents	(1,147,574)	(2,848,338)
Cash, restricted cash, and cash equivalents beginning	8,768,156	11,757,930
Cash, restricted cash, and cash equivalents at ending	7,620,582	8,909,592
Cash paid during the year for:
Interest	1,022	573
Supplemental Non-Cash Items
Initial recognition of warrant liability		135,125
Reclassification from liability to be settled in stock to additional paid in capital		21,420
Fair market value of stock granted in connection with acquisitions		$ 7,122,500